| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |